| keratinocyte differentiation | GO:0030216 | 48 | 0.612 | |
| intermediate filament cytoskeleton organization | GO:0045104 | 26 | 0.563 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.525 | |
| skin development | GO:0043588 | 220 | 0.446 | Human |
| epidermis development | GO:0008544 | 187 | 0.423 | Human |
| intermediate filament based process | GO:0045103 | 27 | 0.422 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.373 | |
| hepatocyte apoptotic process | GO:0097284 | 11 | 0.367 | |
| gland development | GO:0048732 | 330 | 0.328 | Human |
| regulation of protein transport | GO:0051223 | 163 | 0.326 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.302 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.292 | |
| placenta development | GO:0001890 | 140 | 0.275 | |
| regulation of keratinocyte differentiation | GO:0045616 | 11 | 0.265 | |
| response to growth factor | GO:0070848 | 198 | 0.264 | Human |
| membrane organization | GO:0061024 | 245 | 0.259 | |
| protein secretion | GO:0009306 | 111 | 0.254 | |
| forebrain development | GO:0030900 | 302 | 0.241 | |
| tumor necrosis factor mediated signaling pathway | GO:0033209 | 13 | 0.238 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.235 | |
| wound healing | GO:0042060 | 157 | 0.232 | |
| hair cycle | GO:0042633 | 90 | 0.209 | Human |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.203 | |
| hair follicle development | GO:0001942 | 85 | 0.201 | Human |
| striated muscle tissue development | GO:0014706 | 293 | 0.193 | |
| skin morphogenesis | GO:0043589 | 38 | 0.186 | Human |
| muscle tissue development | GO:0060537 | 308 | 0.179 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.165 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.165 | Human |
| regulation of kinase activity | GO:0043549 | 249 | 0.161 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.159 | |
| molting cycle | GO:0042303 | 90 | 0.155 | Human |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.153 | |
| developmental maturation | GO:0021700 | 193 | 0.150 | |
| regeneration | GO:0031099 | 38 | 0.145 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.143 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.141 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.135 | |
| maintenance of cell number | GO:0098727 | 3 | 0.132 | |
| cell growth | GO:0016049 | 130 | 0.132 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.127 | Human |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.126 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.126 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.125 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.124 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.123 | |
| ossification | GO:0001503 | 216 | 0.121 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.120 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.119 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.119 | |
| metanephros development | GO:0001656 | 79 | 0.116 | |
| nephron development | GO:0072006 | 109 | 0.115 | |
| regulation of secretion | GO:0051046 | 274 | 0.114 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.112 | |
| interleukin 8 production | GO:0032637 | 4 | 0.111 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.111 | |
| intermediate filament organization | GO:0045109 | 15 | 0.110 | |
| mesoderm development | GO:0007498 | 100 | 0.110 | |
| axon guidance | GO:0007411 | 141 | 0.110 | |
| skeletal system development | GO:0001501 | 356 | 0.108 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.108 | |
| synaptic transmission | GO:0007268 | 329 | 0.103 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.102 | |
| water homeostasis | GO:0030104 | 27 | 0.102 | |
| negative regulation of growth | GO:0045926 | 99 | 0.100 | |
| cell fate commitment | GO:0045165 | 210 | 0.098 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.097 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.096 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.095 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.094 | |
| epithelial cell development | GO:0002064 | 159 | 0.094 | |
| digestive tract development | GO:0048565 | 190 | 0.094 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.094 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.092 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.092 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.091 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.090 | |
| ear development | GO:0043583 | 200 | 0.090 | |
| gtp catabolic process | GO:0006184 | 143 | 0.089 | |
| cell maturation | GO:0048469 | 127 | 0.088 | |
| regulation of kidney development | GO:0090183 | 40 | 0.088 | |
| axonogenesis | GO:0007409 | 274 | 0.088 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.087 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.086 | |
| renal vesicle induction | GO:0072034 | 3 | 0.086 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.085 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.085 | |
| regionalization | GO:0003002 | 337 | 0.084 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.084 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.083 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.083 | |
| embryonic placenta development | GO:0001892 | 98 | 0.082 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.082 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.082 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.081 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.081 | |
| regulation of hair follicle development | GO:0051797 | 9 | 0.081 | |
| ureteric bud development | GO:0001657 | 94 | 0.080 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.079 | |
| nephron epithelium development | GO:0072009 | 92 | 0.079 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.079 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.078 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.078 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.077 | |
| positive regulation of growth | GO:0045927 | 104 | 0.077 | |
| keratinization | GO:0031424 | 9 | 0.077 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.077 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.076 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.075 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.075 | |
| kidney development | GO:0001822 | 213 | 0.074 | |
| positive regulation of hair follicle development | GO:0051798 | 6 | 0.074 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.074 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.073 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.073 | |
| positive regulation of interferon gamma production | GO:0032729 | 39 | 0.072 | |
| response to nutrient levels | GO:0031667 | 109 | 0.072 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.072 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.072 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.071 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.071 | |
| tissue regeneration | GO:0042246 | 22 | 0.071 | |
| endocrine system development | GO:0035270 | 98 | 0.070 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.069 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.069 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.068 | |
| gtp metabolic process | GO:0046039 | 144 | 0.068 | |
| appendage development | GO:0048736 | 166 | 0.068 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.068 | |
| palate development | GO:0060021 | 76 | 0.068 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.068 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.068 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.067 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.067 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.065 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.065 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.065 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.065 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.064 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.064 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.064 | |
| multicellular organism growth | GO:0035264 | 161 | 0.063 | |
| regulation of epidermal cell differentiation | GO:0045604 | 21 | 0.063 | |
| defense response to bacterium | GO:0042742 | 119 | 0.063 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.062 | |
| rhythmic process | GO:0048511 | 174 | 0.062 | |
| hormone secretion | GO:0046879 | 128 | 0.062 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.061 | |
| regulation of hair cycle | GO:0042634 | 11 | 0.061 | |
| renal inner medulla development | GO:0072053 | 3 | 0.060 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.060 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.059 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.059 | |
| inflammatory response | GO:0006954 | 244 | 0.059 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.058 | |
| syncytium formation | GO:0006949 | 43 | 0.057 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.057 | |
| chemotaxis | GO:0006935 | 247 | 0.057 | |
| cytokine secretion | GO:0050663 | 72 | 0.056 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.056 | |
| telencephalon development | GO:0021537 | 186 | 0.056 | |
| ear morphogenesis | GO:0042471 | 118 | 0.056 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.055 | |
| cell adhesion | GO:0007155 | 329 | 0.055 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.055 | |
| response to tumor necrosis factor | GO:0034612 | 26 | 0.055 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.055 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.055 | |
| camera type eye development | GO:0043010 | 266 | 0.054 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.054 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.054 | |
| regulation of b cell proliferation | GO:0030888 | 39 | 0.054 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.052 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.052 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.052 | |
| neuron projection extension | GO:1990138 | 64 | 0.052 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.051 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.051 | |
| peptide transport | GO:0015833 | 133 | 0.051 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.051 | |
| cytokine production | GO:0001816 | 319 | 0.051 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.051 | |
| positive regulation of epidermis development | GO:0045684 | 13 | 0.051 | |
| cardiac septum development | GO:0003279 | 59 | 0.050 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.050 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.050 | |
| oviduct development | GO:0060066 | 3 | 0.050 | |
| neuron migration | GO:0001764 | 122 | 0.050 | |
| cervix development | GO:0060067 | 2 | 0.050 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.050 | |
| amide transport | GO:0042886 | 138 | 0.050 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.050 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.050 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.049 | |
| regulation of protein localization | GO:0032880 | 231 | 0.049 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.049 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.049 | |
| pallium development | GO:0021543 | 120 | 0.048 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.048 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.048 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.048 | |
| extracellular structure organization | GO:0043062 | 148 | 0.047 | |
| gas homeostasis | GO:0033483 | 3 | 0.047 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.047 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.047 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.047 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.047 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.046 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.046 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.046 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.045 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.045 | Human |
| regulation of anagen | GO:0051884 | 1 | 0.045 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.044 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.044 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.044 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.044 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.044 | |
| regulation of cell growth | GO:0001558 | 91 | 0.044 | |
| regulation of water loss via skin | GO:0033561 | 16 | 0.043 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.043 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.043 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.043 | |
| compound eye development | GO:0048749 | 1 | 0.043 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.042 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.042 | |
| plasma membrane organization | GO:0007009 | 90 | 0.042 | |
| cellular homeostasis | GO:0019725 | 240 | 0.042 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.042 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.041 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.041 | |
| transmembrane transport | GO:0055085 | 412 | 0.041 | |
| renal tubule development | GO:0061326 | 87 | 0.040 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.040 | |
| endomembrane system organization | GO:0010256 | 147 | 0.040 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.040 | |
| kidney epithelium development | GO:0072073 | 121 | 0.040 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.040 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.040 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.040 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.040 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.040 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.040 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.039 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.039 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.039 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.039 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.039 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.039 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.039 | |
| cellular response to tumor necrosis factor | GO:0071356 | 21 | 0.039 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.039 | |
| renal system development | GO:0072001 | 225 | 0.039 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.038 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.038 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.038 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.038 | |
| positive regulation of kidney development | GO:0090184 | 28 | 0.038 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.038 | |
| cardiac atrium development | GO:0003230 | 24 | 0.038 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.038 | |
| regulation of metanephros development | GO:0072215 | 15 | 0.038 | |
| interleukin 6 production | GO:0032635 | 58 | 0.037 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.037 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.037 | |
| muscle system process | GO:0003012 | 141 | 0.037 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.037 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.037 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.037 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.037 | |
| sensory perception | GO:0007600 | 245 | 0.037 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.037 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.036 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.036 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.036 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.036 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.036 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.036 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.036 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.036 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.036 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.035 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.035 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.035 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.035 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.035 | |
| axon ensheathment | GO:0008366 | 76 | 0.035 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.035 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.035 | |
| heart morphogenesis | GO:0003007 | 178 | 0.035 | Mouse |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.035 | |
| heart growth | GO:0060419 | 45 | 0.035 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.034 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.034 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.034 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.034 | |
| synapse organization | GO:0050808 | 125 | 0.034 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.034 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.034 | |
| limbic system development | GO:0021761 | 72 | 0.034 | |
| actin filament organization | GO:0007015 | 113 | 0.034 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.034 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.034 | |
| angiogenesis | GO:0001525 | 201 | 0.034 | |
| chromatin organization | GO:0006325 | 206 | 0.033 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.033 | |
| immune effector process | GO:0002252 | 321 | 0.033 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.033 | |
| myotube cell development | GO:0014904 | 60 | 0.033 | |
| regulation of interleukin 1 beta production | GO:0032651 | 25 | 0.033 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.033 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.033 | |
| forebrain cell migration | GO:0021885 | 58 | 0.033 | |
| visual perception | GO:0007601 | 52 | 0.032 | |
| feeding behavior | GO:0007631 | 62 | 0.032 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.032 | |
| organ growth | GO:0035265 | 117 | 0.032 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.032 | |
| anion transport | GO:0006820 | 177 | 0.032 | |
| gliogenesis | GO:0042063 | 141 | 0.032 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.032 | |
| diencephalon development | GO:0021536 | 63 | 0.032 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.032 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.032 | |
| interleukin 1 production | GO:0032612 | 31 | 0.032 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.032 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.032 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.032 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.032 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.031 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.031 | |
| defense response to other organism | GO:0098542 | 197 | 0.031 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.031 | |
| regulation of system process | GO:0044057 | 200 | 0.031 | |
| endocrine process | GO:0050886 | 39 | 0.031 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.031 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.031 | |
| endodermal digestive tract morphogenesis | GO:0061031 | 4 | 0.031 | |
| cartilage development | GO:0051216 | 140 | 0.031 | |
| response to amino acid | GO:0043200 | 37 | 0.030 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.030 | |
| olfactory bulb interneuron differentiation | GO:0021889 | 12 | 0.030 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.030 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.030 | |
| response to parathyroid hormone | GO:0071107 | 3 | 0.030 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.030 | |
| lung induction | GO:0060492 | 3 | 0.030 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.030 | |
| striated muscle cell development | GO:0055002 | 125 | 0.030 | |
| cardiac chamber development | GO:0003205 | 108 | 0.029 | |
| myelination | GO:0042552 | 74 | 0.029 | |
| regulation of jun kinase activity | GO:0043506 | 40 | 0.029 | |
| urogenital system development | GO:0001655 | 261 | 0.029 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.029 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.029 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.029 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.028 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.028 | |
| trabecula formation | GO:0060343 | 24 | 0.028 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.028 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.028 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.028 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.028 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.028 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.028 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.028 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.028 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.028 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.028 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.028 | |
| nephron tubule development | GO:0072080 | 84 | 0.028 | |
| positive regulation of interleukin 6 production | GO:0032755 | 37 | 0.028 | |
| protein maturation | GO:0051604 | 176 | 0.028 | |
| myoblast differentiation | GO:0045445 | 52 | 0.028 | |
| loop of henle development | GO:0072070 | 10 | 0.028 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.028 | |
| innate immune response | GO:0045087 | 157 | 0.027 | |
| hormone metabolic process | GO:0042445 | 86 | 0.027 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.027 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.027 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.027 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.027 | |
| mesonephros development | GO:0001823 | 97 | 0.027 | |
| paraxial mesoderm development | GO:0048339 | 18 | 0.027 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.027 | |
| amine metabolic process | GO:0009308 | 45 | 0.027 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.027 | |
| mapk cascade | GO:0000165 | 281 | 0.027 | |
| response to inorganic substance | GO:0010035 | 96 | 0.027 | |
| regulation of branching involved in salivary gland morphogenesis | GO:0060693 | 11 | 0.027 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.027 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.027 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.027 | |
| biomineral tissue development | GO:0031214 | 64 | 0.027 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.026 | |
| mitochondrion organization | GO:0007005 | 134 | 0.026 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.026 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.026 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.026 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.026 | |
| intestinal epithelial cell maturation | GO:0060574 | 2 | 0.026 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.026 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.026 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.026 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.026 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.026 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.026 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.026 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.026 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.026 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.026 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.026 | |
| mesenchymal epithelial cell signaling | GO:0060638 | 9 | 0.026 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.026 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.026 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.026 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.025 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.025 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.025 | |
| metanephric renal vesicle morphogenesis | GO:0072283 | 12 | 0.025 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.025 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.025 | |
| protein oligomerization | GO:0051259 | 67 | 0.025 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.025 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.025 | |
| blastocyst development | GO:0001824 | 80 | 0.025 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.025 | |
| hippocampus development | GO:0021766 | 52 | 0.025 | |
| response to starvation | GO:0042594 | 65 | 0.025 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.025 | |
| protein processing | GO:0016485 | 163 | 0.025 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.024 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.024 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.024 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.024 | |
| response to calcium ion | GO:0051592 | 20 | 0.024 | |
| salivary gland morphogenesis | GO:0007435 | 33 | 0.024 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.024 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.024 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.024 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.024 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.024 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.024 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.024 | |
| detection of stimulus | GO:0051606 | 84 | 0.024 | |
| positive regulation of muscle tissue development | GO:1901863 | 32 | 0.024 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.024 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.024 | |
| regulation of interleukin 1 secretion | GO:0050704 | 15 | 0.024 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.024 | |
| subpallium neuron fate commitment | GO:0060163 | 2 | 0.024 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.024 | |
| midgut development | GO:0007494 | 4 | 0.023 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.023 | |
| tube formation | GO:0035148 | 140 | 0.023 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.023 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.023 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.023 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.023 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.023 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.023 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.023 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.023 | |
| muscle contraction | GO:0006936 | 101 | 0.023 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.023 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.023 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.023 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.023 | |
| positive regulation of canonical wnt signaling pathway | GO:0090263 | 29 | 0.023 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.023 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.023 | |
| cartilage morphogenesis | GO:0060536 | 11 | 0.023 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.023 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.023 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.023 | |
| mammary gland epithelial cell proliferation | GO:0033598 | 24 | 0.023 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.022 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.022 | |
| stem cell differentiation | GO:0048863 | 268 | 0.022 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.022 | |
| b cell proliferation | GO:0042100 | 53 | 0.022 | |
| circadian rhythm | GO:0007623 | 114 | 0.022 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.022 | |
| response to steroid hormone | GO:0048545 | 56 | 0.022 | |
| regulation of defense response | GO:0031347 | 233 | 0.022 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.022 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.022 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.022 | |
| endoderm development | GO:0007492 | 45 | 0.022 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.022 | |
| ventricular septum development | GO:0003281 | 42 | 0.022 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.022 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.022 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.022 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.022 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.022 | |
